These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 13130338)
21. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Hely MA; Morris JG; Reid WG; Trafficante R Mov Disord; 2005 Feb; 20(2):190-9. PubMed ID: 15551331 [TBL] [Abstract][Full Text] [Related]
22. The video images of sleep attacks in Parkinson's disease. Hirayama M; Nakamura T; Hori N; Koike Y; Sobue G Mov Disord; 2008 Jan; 23(2):288-90. PubMed ID: 18044704 [TBL] [Abstract][Full Text] [Related]
23. Multiparity after an initial diagnosis of Parkinson's disease: a report on a rare case. Campos-Sousa RN; Almeida KJ; Dos Santos AR; Lopes-Costa PV; da Silva BB Fertil Steril; 2008 Nov; 90(5):2005.e1-2. PubMed ID: 18377902 [TBL] [Abstract][Full Text] [Related]
28. Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease. Antonini A; Mancini F; Canesi M; Zangaglia R; Isaias IU; Manfredi L; Pacchetti C; Zibetti M; Natuzzi F; Lopiano L; Nappi G; Pezzoli G Neurodegener Dis; 2008; 5(3-4):244-6. PubMed ID: 18322402 [TBL] [Abstract][Full Text] [Related]
29. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease. Parkinson Study Group CALM Cohort Investigators Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655 [TBL] [Abstract][Full Text] [Related]
30. Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson's disease. Religa D; Czyzewski K; Styczynska M; Peplonska B; Lokk J; Chodakowska-Zebrowska M; Stepien K; Winblad B; Barcikowska M Neurosci Lett; 2006 Aug; 404(1-2):56-60. PubMed ID: 16787708 [TBL] [Abstract][Full Text] [Related]
31. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Cools R Neurosci Biobehav Rev; 2006; 30(1):1-23. PubMed ID: 15935475 [TBL] [Abstract][Full Text] [Related]
32. [Juvenile Parkinson's disease and recurring prematurity. Case report]. Ha DE; Legendre G; Colau JC Gynecol Obstet Fertil; 2007 Mar; 35(3):224-7. PubMed ID: 17293151 [TBL] [Abstract][Full Text] [Related]
33. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614 [TBL] [Abstract][Full Text] [Related]
34. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life. Grosset KA; Grosset DG Mov Disord; 2005 May; 20(5):616-9. PubMed ID: 15719417 [TBL] [Abstract][Full Text] [Related]
35. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation. da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485 [TBL] [Abstract][Full Text] [Related]
36. [Levodopa and cognitive disorders in Parkinson's disease]. Leiva-Santana C; Alvarez-Saúco M Rev Neurol; 2006 Jul 16-31; 43(2):95-100. PubMed ID: 16838257 [TBL] [Abstract][Full Text] [Related]
37. Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy. Bouhaddi M; Vuillier F; Fortrat JO; Cappelle S; Henriet MT; Rumbach L; Regnard J Auton Neurosci; 2004 Nov; 116(1-2):30-8. PubMed ID: 15556835 [TBL] [Abstract][Full Text] [Related]
38. [Risk factors associated to the presentation of episodes of major depression in a population of outpatients with Parkinson's disease]. Chaná-Cuevas P; Juri-Claverías C; Alburquerque D; Soto-Olmedo MJ; Benavides-Canales O Rev Neurol; 2006 May 1-15; 42(9):521-4. PubMed ID: 16676274 [TBL] [Abstract][Full Text] [Related]
39. [Influence of levodopa on cognition of idiopathic Parkinson's disease]. Alonso-Prieto E; Michel-Esteban E; Trujillo-Matienzo C; Palmero-Soler E Neurologia; 2004 Dec; 19(10):710-8. PubMed ID: 15568168 [TBL] [Abstract][Full Text] [Related]
40. Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias. Calon F; Dridi M; Hornykiewicz O; Bédard PJ; Rajput AH; Di Paolo T Brain; 2004 May; 127(Pt 5):1075-84. PubMed ID: 15033896 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]